Literature DB >> 12652158

Role of nitric oxide in the pathophysiology of heart failure.

Hunter C Champion1, Michel W Skaf, Joshua M Hare.   

Abstract

Nitric oxide (NO) plays critical roles in the regulation of integrated cardiac and vascular function and homeostasis. An understanding of the physiologic role and relative contribution of the three NO synthase isoforms (neuronal--NOS1, inducible--NOS2, and endothelial--NOS3) is imperative to comprehend derangements of the NO signaling pathway in the failing cardiovascular system. Several theories of NO and its regulation have developed as explanations for the divergent observations from studies in health and disease states. Here we review the physiologic and pathophysiologic influence of NO on cardiac function, in a framework that considers several theories of altered NO signaling in heart failure. We discuss the notion of spatial compartmentalization of NO signaling within the myocyte in an effort to reconcile many controversies about derangements in the influences of NO in the heart and vasculature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12652158     DOI: 10.1023/a:1022142904202

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  124 in total

Review 1.  Nitrosylation. the prototypic redox-based signaling mechanism.

Authors:  J S Stamler; S Lamas; F C Fang
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

2.  Factors released from endocardium of the ferret and pig modulate myocardial contraction.

Authors:  J A Smith; A M Shah; M J Lewis
Journal:  J Physiol       Date:  1991-08       Impact factor: 5.182

3.  Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation.

Authors:  Y W Xie; P M Kaminski; M S Wolin
Journal:  Circ Res       Date:  1998-05-04       Impact factor: 17.367

4.  Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains.

Authors:  J E Brenman; D S Chao; S H Gee; A W McGee; S E Craven; D R Santillano; Z Wu; F Huang; H Xia; M F Peters; S C Froehner; D S Bredt
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

5.  Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness.

Authors:  J M Hare; M M Givertz; M A Creager; W S Colucci
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

6.  Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes.

Authors:  M G Vila-Petroff; A Younes; J Egan; E G Lakatta; S J Sollott
Journal:  Circ Res       Date:  1999-05-14       Impact factor: 17.367

7.  Augmented age-associated innate immune responses contribute to negative inotropic and lusitropic effects of lipopolysaccharide and interferon gamma.

Authors:  G O Rosas; S J Zieman; M Donabedian; K Vandegaer; J M Hare
Journal:  J Mol Cell Cardiol       Date:  2001-10       Impact factor: 5.000

8.  Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts.

Authors:  G Kojda; K Kottenberg; E Noack
Journal:  Eur J Pharmacol       Date:  1997-09-10       Impact factor: 4.432

9.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

10.  The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta.

Authors:  D J Pinsky; B Cai; X Yang; C Rodriguez; R R Sciacca; P J Cannon
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  5 in total

Review 1.  Evidence for impaired vagus nerve activity in heart failure.

Authors:  Steve Bibevski; Mark E Dunlap
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

2.  Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism.

Authors:  Jochen Steppan; Sungwoo Ryoo; Karl H Schuleri; Chris Gregg; Rani K Hasan; A Ron White; Lukasz J Bugaj; Mehnaz Khan; Lakshmi Santhanam; Daniel Nyhan; Artin A Shoukas; Joshua M Hare; Dan E Berkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

3.  Chemogenetic activation of intracardiac cholinergic neurons improves cardiac function in pressure overload-induced heart failure.

Authors:  Jhansi Dyavanapalli; Aloysius James Hora; Joan B Escobar; John Schloen; Mary Kate Dwyer; Jeannette Rodriguez; Christopher F Spurney; Matthew W Kay; David Mendelowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-15       Impact factor: 4.733

4.  Prolonged Action Potential and After depolarizations Are Not due to Changes in Potassium Currents in NOS3 Knockout Ventricular Myocytes.

Authors:  Honglan Wang; Ingrid M Bonilla; Xin Huang; Quanhua He; Mark J Kohr; Cynthia A Carnes; Mark T Ziolo
Journal:  J Signal Transduct       Date:  2012-08-28

5.  Quercetin reduces inflammatory responses in LPS-stimulated cardiomyoblasts.

Authors:  Cristina Angeloni; Silvana Hrelia
Journal:  Oxid Med Cell Longev       Date:  2012-05-22       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.